Page 2 - Simplify Disc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Good day. And welcome to the NuVasive Inc. Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Matt Harbaugh, Executive Vice President and Chief Financial Officer. Thank you. You may begin. Matt Harbaugh -- Executive Vice President and Chief Financial Officer Thank you. Welcome to NuVasive's Fourth Quarter and Full Year 2020 Earnings Call. The company's earnings release, which we issued earlier this afternoon, has been filed on Form 8-K with th...

NuVasive Announces First Quarter 2021 Financial Results -- Net sales increase driven by U.S. procedural volume improvement throughout the quarter and strong international growth -- -- Simplify Cervical Artificial Disc receives FDA approval for two-level cervical total disc replacement -- -- R&D investment increase year over year to advance spine procedural segments and enabling technology roadmap -- News provided by Share this article Share this article SAN DIEGO, May 5, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spin...

Share this article Share this article SAN DIEGO, April 6, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify ® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR). "This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfol...

FDA Approves NuVasive's Simplify Disc For Two-Level Cervical Total Disc Replacement WASHINGTON (dpa-AFX) - NuVasive, Inc. (NUVA), Tuesday announced that the NuVasive Simplify Cervical Artificial Disc received approval from the U.S. Food and Drug Administration for two-level cervical total disc replacement. 'This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio,' said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. 'There is immense surgeon excitement for this latest edition...

NuVasive Acquires Simplify Medical Simplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment Expands growth opportunities and further differentiates Company's comprehensive portfolio across ACDF, PCF, and cTDR procedures News provided by Share this article Share this article SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announ...